You are here
GILD Stock: This Could Be a Big Problem for Gilead Sciences, Inc. Market Trends 

GILD Stock: This Could Be a Big Problem for Gilead Sciences, Inc.

GILD Stock: This Could Be a Big Problem for Gilead Sciences, Inc. Gilead Sciences, Inc. (NASDAQ:GILD) stock is a heavyweight in the biotech space; the company bolsters a $105.0-billion market cap and ranks high among its competitors like GlaxoSmithKline plc(NYSE:GSK) and Pfizer Inc. (NYSE:PFE). The biotech space has been known to make and break many hearts, and I am not talking about the millions of patients that are saved and treated by the medical breakthroughs that many of these companies have brought to market. This sector is known to provide…

Read More